Abstract Library

#2192 Immunohistochemical Profiles in 81 Patients with Resected Insulinomas

Introduction: Ninety percent of insulinomas are benign. However, there are no well-defined immunohistochemical criteria that can distinguish a benign from a malignant insulinoma

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Andreassen M

Authors: Andreassen M, Ilett E, Slater E, Wiese D, Hansen C,

Keywords: insulinoma, malignancy, immunohistochemistry,

#600 Neuroendocrine Neoplasms: Epidemiological Trends in Queensland, Australia

Introduction: Various studies pertaining to neuroendocrine neoplasms (NENs) have revealed trends in incidence and mortality over time, and regional variations. The WHO 2010 classification has attempted to more accurately reflect the differing prognoses of this heterogeneous patient population by defining various patient subsets.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Thaker D

Authors: Hansen A, Zarate D, Wyld D,

Keywords: NEC,

#492 Should Primary Hyperparathyroidism at Age Below 40 Years Always Lead to Search for MEN-1, Despite Presence of Other Plausible Explanations?

Introduction: A 30-year-old female patient with inherited osteogenesis imperfecta (OI) Type 1 was referred due to hypercalcaemia and suspicion of primary hyperparathyroidism (pHPT). She had serum ca2+ 1.56 mmol/L, serum parathyroid hormone 115 ng/ml (< 70), and pHPT was diagnosed, but no scan uptake. By exploratory neck surgery, all parathyroid glands were hyperplastic and 3 ½ parathyroid + thymus were removed. The HPT was hypothesised to be due to abnormal calcium metabolism from OI (J Endocrinol Invest 1999), although not described previously.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Feldt-Rasmussen U, Rasmussen �, Friis-Hansen L,

Keywords: MEN-1, screening, pHPT,

#472 Detection of Liver Metastases and Prognostic Value of Functional and Anatomical Imaging in Patients with Neuroendocrine Tumors

Introduction: Liver metastases (LM) are frequent in patients with neuroendocrine tumors (NETs) and are associated with decreased overall survival (OS). Several treatment options are available depending on degree, localization, size and number of LM. For optimal choice of treatment and correct staging, accurate imaging modalities are crucial.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Knigge U, Binderup T, Federspiel B, Palnæs Hansen C, Loft A,

Keywords: ,

#470 Overall Survival of Well-Differentiated Neuroendocrine Tumors Evaluated by F-18-FDG-PET

Introduction: Today, grading, and thereby choice of treatment strategy for patients with neuroendocrine (NE) tumors, is mainly based on the proliferation index, Ki-67. As a supplement to this pathological evaluation, a whole body image analysis could be of value.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Binderup T, Knigge U, Federspiel B, Palnæs Hansen C, Loft A,

Keywords: Survival, FDG-PET, WHO grade I & II,